BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28759773)

  • 21. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
    Elnifro E; Nisha AK; Almabsoot M; Daeki A; Mujber N; Muscat J
    J Infect Dev Ctries; 2009 Apr; 3(3):218-20. PubMed ID: 19759477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
    Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
    J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological detection of human parvovirus B19 infection and associated risk factors among pregnant women in Jigawa State, Nigeria.
    Safiyanu MB; Akande AO; Babayo A; Umar J; Abdullahi IN
    J Immunoassay Immunochem; 2021 Jul; 42(4):380-392. PubMed ID: 33591885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern of parvovirus B 19 infection during different trimesters of pregnancy in Kuwait.
    Makhseed M; Pacsa A; Ahmed MA; Essa SS
    Infect Dis Obstet Gynecol; 1999; 7(6):287-92. PubMed ID: 10598918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-negative serology in patients with acute parvovirus B19 infection.
    Bredl S; Plentz A; Wenzel JJ; Pfister H; Möst J; Modrow S
    J Clin Virol; 2011 Jun; 51(2):115-20. PubMed ID: 21530386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cytomegalovirus, human parvovirus B19, and herpes simplex virus-1/2 in women with first-trimester spontaneous abortions.
    Zhou Y; Bian G; Zhou Q; Gao Z; Liao P; Liu Y; He M
    J Med Virol; 2015 Oct; 87(10):1749-53. PubMed ID: 25976377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
    Weseslindtner L; Aberle JH; Hedman L; Hedman K
    J Infect Dis; 2017 Jan; 215(2):214-220. PubMed ID: 27789725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.
    Enders M; Weidner A; Rosenthal T; Baisch C; Hedman L; Söderlund-Venermo M; Hedman K
    J Infect Dis; 2008 Jan; 197(1):58-62. PubMed ID: 18171285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of perinatal transmission of rubella and parvovirus B19 in Jordanian pregnant women.
    Bdour S
    Vaccine; 2006 Apr; 24(16):3309-12. PubMed ID: 16460842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
    Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
    J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of parvovirus B19 antibodies in pregnant women in northern Benin.
    De Paschale M; Ceriani C; Cerulli T; Cagnin D; Cavallari S; Zaongo D; Diombo K; Priuli G; Viganò P; Finazzi S; Clerici P
    Trop Med Int Health; 2023 Mar; 28(3):226-231. PubMed ID: 36647788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lack of routine surveillance of Parvovirus B19 infection in pregnancy prevents an accurate understanding of this regular cause of fetal loss and the risks posed by occupational exposure.
    Watt AP; Brown M; Pathiraja M; Anbazhagan A; Coyle PV
    J Med Microbiol; 2013 Jan; 62(Pt 1):86-92. PubMed ID: 22977072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants?
    Molenaar-de Backer MW; Russcher A; Kroes AC; Koppelman MH; Lanfermeijer M; Zaaijer HL
    J Clin Virol; 2016 Nov; 84():19-23. PubMed ID: 27664778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk of human parvovirus B19 infection in day-care employees: a cohort study among pregnant workers during an epidemic in Finland.
    Riipinen A; Sallmén M; Hedman L; Ojajärvi A; Lindbohm ML; Meriluoto M; Surcel HM; Taskinen H; Nuutila M; Karikoski R; Hedman K; Söderlund-Venermo M
    Occup Environ Med; 2014 Dec; 71(12):836-41. PubMed ID: 25074899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
    Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
    J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Parvovirus B19 infection--dangerous for the fetus].
    Ebbing C; Njølstad G; Kiserud T
    Tidsskr Nor Laegeforen; 2004 Sep; 124(18):2354-6. PubMed ID: 15467798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 1994 human parvovirus B19 epidemic in Denmark: diagnostic and epidemiological experience.
    Jensen IP; Schou O; Vestergaard BF
    APMIS; 1998 Sep; 106(9):843-8. PubMed ID: 9808410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors.
    Reinheimer C; Allwinn R; Doerr HW; Wittek M
    Infection; 2010 Oct; 38(5):381-5. PubMed ID: 20556472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of parvovirus B19 infection in women of childbearing age in England and Wales.
    Vyse AJ; Andrews NJ; Hesketh LM; Pebody R
    Epidemiol Infect; 2007 Nov; 135(8):1354-62. PubMed ID: 17291377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.